Skip to main content
Arvee Laboratories (India) Limited logo

Arvee Laboratories (India) Limited — Investor Relations & Filings

Ticker · ARVEE ISIN · INE006Z01016 LEI · 33580075Q2EAWYCO4C50 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2021-02-12 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India ARVEE

About Arvee Laboratories (India) Limited

http://arveelabs.com/

Arvee Laboratories (India) Limited specializes in the manufacturing and export of specialty chemicals and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds, including Dimethyl 5-Sulfoisophthalate Sodium Salt (DMSIP), 5-Sulfoisophthalic Acid Monosodium Salt, and various other aromatic intermediates. These products serve as critical components in the textile, polymer, and pharmaceutical sectors. Arvee Laboratories emphasizes research and development to enhance its chemical synthesis processes and maintain international quality standards. Its operations involve complex chemical reactions such as sulfonation, esterification, and reduction, catering to a diverse global clientele requiring specialized chemical solutions for industrial applications.

Recent filings

Filing Released Lang Actions
Appointment
Board/Management Information Classification · 95% confidence The document provides a profile of an individual named Neetu Jalan, detailing her qualifications, experience, and role as an independent director on the Board of Directors, including committee membership. There is no financial data, report, or announcement of voting results. This type of information typically falls under announcements related to board or management changes or profiles. Therefore, the document is best classified as Board/Management Information (MANG). The document is short and focused solely on the individual's profile, confirming it is not a report or other filing type.
2021-02-12 English
Reply to Clarification- Financial results
Interim / Quarterly Report Classification · 95% confidence The document contains detailed unaudited financial results for the half year ended 30th September 2020, including revenue, expenses, profit before tax, tax expenses, earnings per share, and a statement of assets and liabilities. It also mentions the review and approval of these financial statements by the audit committee and board of directors, and a limited review by statutory auditors. The presence of comprehensive financial data and analysis for a half-year period indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2020-12-07 English
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding the non-applicability of related party transactions due to the company's paid-up share capital and net worth being below certain thresholds. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations and states that corporate governance provisions are not applicable. The document is short (1557 characters) and is essentially a regulatory compliance communication rather than a financial report or detailed filing. It does not contain financial statements, audit information, or detailed management discussion. It is a regulatory announcement or compliance statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-04 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Scrutinizer's Report and Voting Results of a Postal Ballot conducted by Arvee Laboratories (India) Limited. It references the submission of the Scrutinizer's Report and voting results pursuant to SEBI regulations and the Companies Act, 2013. The content includes detailed voting results, appointment of the Scrutinizer, and procedural details of the postal ballot. This is not an Annual Report, Earnings Release, or Management Report, but a formal report on the voting outcome of a shareholder resolution. According to the filing definitions, this matches the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length and detail confirm it is the report itself, not just an announcement of publication. Therefore, the correct classification is DVA with high confidence.
2020-11-24 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Arvee Laboratories (India) Limited dated November 5, 2020, regarding the outcome of a board meeting. It includes unaudited financial results for the half year ended September 30, 2020, along with a limited review report by statutory auditors. The document contains comprehensive financial data such as revenue, expenses, profit before tax, earnings per share, and a statement of assets and liabilities. It also references compliance with SEBI regulations and includes notes on accounting standards and segment reporting. The presence of substantive financial statements and analysis for a half-year period indicates this is an Interim / Quarterly Report rather than a mere announcement or certification. The document length (15,000 characters) and detailed financial content confirm it is not a short announcement or a certification letter. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2020-11-05 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice regarding a Postal Ballot and Remote E-Voting process for shareholders of Arvee Laboratories (India) Limited. It includes references to the Companies Act, SEBI regulations, and details about the voting process, dates, and resolutions to be passed by shareholders. The document is not a financial report, earnings release, or management discussion but rather a formal notice to shareholders to vote on a special resolution concerning migration of listing from SME platform to the main board of NSE. It also includes procedural instructions for voting and appointment of a scrutinizer. This type of document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder voting procedures and resolutions. However, since this document is the notice for the postal ballot and not the actual voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings or resolutions. The document is lengthy (15,000 characters) and contains detailed voting instructions and explanatory statements, consistent with PSI filings.
2020-10-26 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.